Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Inflammation; Weakness; Joint pain; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Inflammation), ASTHENIA (Weakness), ARTHRALGIA (Joint pain), HEADACHE (Headache) and FATIGUE (Fatigue) in a 60-year-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 4 microgram. On 17-Jun-2023, the patient experienced INFLAMMATION (Inflammation), ASTHENIA (Weakness), ARTHRALGIA (Joint pain), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, INFLAMMATION (Inflammation), ASTHENIA (Weakness), ARTHRALGIA (Joint pain), HEADACHE (Headache) and FATIGUE (Fatigue) had not resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. Concomitant medication was not provided. It was unknown if the patient experienced any additional symptoms or events. Treatment information was not reported.